Company: AZN
Filing Date: 2025-09-29
Form Type: 6-K
Source: 0001104659-25-094039
Chunk: 40

Company: ASTRAZENECA PLC
Filing Date: 2025-09-29
Form: 6-K
Chunk 40
---
 ​ |

31

TABLE OF CONTENTS

| ​ | “Swedish Listed Shares”                    | ​ | ​ | all of the AstraZeneca Shares held within CREST by Euroclear Sweden AB as custodian for the underlying Shareholders as may be traded on Nasdaq Stockholm;                                                                                                                                                                                                                                                                                                                                                                                                                | ​ |
| ​ | “uncertificated”or“in uncertificated form” | ​ | ​ | refers to a share or other security recorded on the relevant register of the share or security concerned as being held in uncertificated form;                                                                                                                                                                                                                                                                                                                                                                                                                           | ​ |
| ​ | “United Kingdom”or“UK”                     | ​ | ​ | the United Kingdom of Great Britain and Northern Ireland;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | ​ |
| ​ | “United States”or“US”                      | ​ | ​ | the United States of America, its territories and possessions, any state of the United States of America and the District of Columbia and all other areas subject to its jurisdiction;                                                                                                                                                                                                                                                                                                                                                                                   | ​ |
| ​ | “US dollars”or“$”                          | ​ | ​ | the lawful currency of the US;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | ​ |
| ​ | “US Holder”                                | ​ | ​ | a beneficial owner of AstraZeneca Shares or AstraZeneca ADSs that is, for US federal income tax purposes: (i) a citizen or individual resident of the United States, (ii) a corporation, or other entity taxable as a corporation, created or organized in or under the laws of the United States, any state thereof or the District of Columbia, (iii) a trust subject to the control of one or more US persons and the primary supervision of a US court; or (iv) an estate the income of which is subject to US federal income taxation regardless of its source; and | ​ |
| ​ | “Voting Record Time”                       | ​ | ​ | 6:30 p.m. (GMT) on 30 October 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | ​ |

32

TABLE OF CONTENTS

### PART VIINOTICE OF GENERAL MEETING

### NOTICE OF GENERAL MEETING OF ASTRAZENECA PLC
Notice is hereby given that a General Meeting of AstraZeneca PLC (the “

#### Company
”) will be held on the Lumi online platform and at the broadcast venue at the Kia Oval, Kennington, London, SE11 5SS on 3 November